Metformax Sr 500

Metformin Hydrochloride, the active ingredient in Metformax Sr 500, is a biguanide presented as a 500 mg oral tablet for oral use. It is indicated for the management of type 2 diabetes mellitus and works by improving insulin sensitivity and reducing hepatic glucose output.

GNH USA supplies Metformax Sr 500 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformax Sr 500 (metformin) is used in the management of type 2 diabetes mellitus, a disorder of glucose metabolism.

- Type 2 diabetes mellitus: improves glycemic control and lowers fasting blood glucose. - Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes. - Polycystic ovary syndrome: may improve insulin resistance and menstrual regularity.

Metformax Sr 500 may be associated with a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools, often transient. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe hypoglycemia: especially when combined with insulin or sulfonylureas. - Vitamin B12 deficiency: may develop with long‑term use. - Skin rash or hypersensitivity: including Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Acute pancreatitis: rare inflammatory condition of the pancreas.

Before initiating Metformax Sr 500, clinicians should evaluate patient‑specific factors and monitor therapy appropriately.

- Renal function: assess creatinine clearance and avoid use in severe renal impairment. - Hepatic disease: contraindicated in severe liver dysfunction. - Cardiac failure: use with caution due to lactic acidosis risk. - Alcohol consumption: limit intake to reduce metabolic complications. - Pregnancy and lactation: evaluate risk‑benefit; use only if clearly needed. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformax Sr 500 can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of renal impairment and lactic acidosis. - Cimetidine: may raise metformin plasma concentrations. - Alcohol: potentiates lactic acidosis risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes. - NSAIDs: may reduce renal perfusion, increasing metformin exposure. - Thyroid hormones: may alter glucose metabolism, requiring glycemic monitoring.